share_log

JMP Securities Maintains Market Outperform on Aura Biosciences, Lowers Price Target to $19

JMP Securities Maintains Market Outperform on Aura Biosciences, Lowers Price Target to $19

JMP Securities維持Aura Biosciences的市場跑贏大盤,將目標股價下調至19美元
Benzinga ·  2023/11/10 14:40

JMP Securities analyst Jonathan Wolleben maintains Aura Biosciences (NASDAQ:AURA) with a Market Outperform and lowers the price target from $21 to $19.

JMP Securities分析師喬納森·沃勒本維持Aura Biosciences(納斯達克股票代碼:AURA)的市場跑贏大盤,並將目標股價從21美元下調至19美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論